Dr Richards qualified in medicine at St Bartholomew’s Hospital London in 1981; he undertook a period of research looking at the effects of cyclosporine-A on endothelial function at St Thomas’ Hospital London prior to being appointed as Consultant Physician and Nephrologist at The Queen Elizabeth Hospital in Birmingham in 1992. During his time in Birmingham he was actively involved in the development of an electronic patient record with associated drug prescribing system. He went into medical management as Clinical Director, Divisional Director and finally Director of Operations in Birmingham before leaving the NHS and taking up the position of Medical Director for the UK and Ireland for Fresenius Medical Care in 2004. He moved to his current position as the CEO and CMO of SEHA Dialysis Services in 2012. He remains actively interested in clinical research particularly in relation to epidemiology and prevention of chronic kidney disease. He has published more than 50 papers in peer reviewed journals. Dr Richards qualified in medicine at St Bartholomew’s Hospital London in 1981; he undertook a period of research looking at the effects of cyclosporine-A on endothelial function at St Thomas’ Hospital London prior to being appointed as Consultant Physician and Nephrologist at The Queen Elizabeth Hospital in Birmingham in 1992. During his time in Birmingham he was actively involved in the development of an electronic patient record with associated drug prescribing system. He went into medical management as Clinical Director, Divisional Director and finally Director of Operations in Birmingham before leaving the NHS and taking up the position of Medical Director for the UK and Ireland for Fresenius Medical Care in 2004. He moved to his current position as the CEO and CMO of SEHA Dialysis Services in 2012. He remains actively interested in clinical research particularly in relation to epidemiology and prevention of chronic kidney disease. He has published more than 50 papers in peer reviewed journals.

Primary care based automated detection and algorithm driven online decision support improves outcomes for patients with chronic kidney disease